Natera, Inc. , a global leader in cell-free DNA (cfDNA) testing and precision medicine, today announced an advancement in molecular residual disease (MRD)-based risk stratification that is expected to ...

Microsoft is trying to win over communities concerned about AI data centers. The company's president, Brad Smith, is meeting ...

Sentynl Therapeutics Inc. ("Sentynl"), a U.S.-based biopharmaceutical company wholly-owned by Zydus Lifesciences Limited ...